The insulin discovery we forgot.Editorial Policies Community standards Republishing guidelines Friends of The Conversation Analytics Our feeds Donate Get newsletter Who we are Our charter Our team ...

It is the first biosimilar of a rapid-acting insulin product – used to control the blood glucose spike after meals – and only the third insulin biosimilar to be approved in the US.